Acoustic neuroma diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
Replaced content with "__NOTOC__ {{Acoustic neuroma}} {{CMG}}; {{AE}} == Overview == == Diagnostic Study of Choice == ==References== {{Reflist|2}} {{WH}} {{WS}}" Tags: Replaced Visual edit |
|||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
== Overview == | == Overview == | ||
[[Gadolinium]]-enhanced [[MRI]] scan is definitive diagnostic test of acoutic neuroma and can identify [[tumors]] as small as 1-2 millimeter in diameter. On brain MRI, acoustic neuroma characterized by hypointense mass on T1-weighted MRI, and hyperintense mass on T2-weighted MRI. | |||
== Diagnostic Study of Choice == | == Diagnostic Study of Choice == | ||
Revision as of 03:09, 18 January 2019
|
Acoustic neuroma Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Acoustic neuroma diagnostic study of choice On the Web | |
|
American Roentgen Ray Society Images of Acoustic neuroma diagnostic study of choice | |
|
Risk calculators and risk factors for Acoustic neuroma diagnostic study of choice | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Gadolinium-enhanced MRI scan is definitive diagnostic test of acoutic neuroma and can identify tumors as small as 1-2 millimeter in diameter. On brain MRI, acoustic neuroma characterized by hypointense mass on T1-weighted MRI, and hyperintense mass on T2-weighted MRI.